3-chlorobenzoic acid muhimmin abu ne na sinadarai kuma ana amfani da shi sosai a cikin nau'ikan halayen halitta daban-daban.
3-chlorobenzoic acid yana da amfani mai mahimmanci a fannin magunguna. Yana da muhimmin abu na roba don magunguna kamar loratadine da bupropion. Loratadine magani ne na antihistamine na ƙarni na biyu wanda aka saba amfani da shi don magance alamun rashin lafiyan kamar rhinitis na rashin lafiyan, urticaria mai tsanani ko na yau da kullun, conjunctivitis na rashin lafiyan, zazzaɓin ciyawa, da sauran cututtukan fata na rashin lafiyan. Amphetamine yana cikin rukunin magungunan rage radadin amino ketone kuma ya dace da magance baƙin ciki na yau da kullun da kuma marasa lafiya da ke cikin damuwa waɗanda ba su da tasiri sosai ko kuma ba sa jure wa wasu magungunan rage radadin.
Bugu da ƙari, ana amfani da 3-chlorobenzoic acid wajen haɗa rini da magungunan kashe kwari. A matsayin wani muhimmin tubalin gina sinadarai, ana amfani da shi sosai wajen haɗa hadaddun tsarin halitta. Ta hanyar amsawa kamar oxidation, ragewa, da maye gurbinsu, ana iya haɗa nau'ikan sinadarai daban-daban, kamar magunguna, rini, maganin kwari, da sauransu.
3-Kayan Sinadaran Chlorobenzoic acid
Wurin narkewa 153-157 °C (haske)
Tafasawar zafin jiki 274-276°C
yawa 1.496
ma'aunin haske 1.5812 (kimantawa)
Fp 150 °C
Zafin ajiya. A adana a ƙasa da +30°C.
narkewar 0.45g/l
Foda Mai Siffar Crystalline
pka 3.82(a 25℃)
launi Fari zuwa beige
Narkewar Ruwa <0.1 g/100 mL a 19.5 ºC
Kasuwa 14,2123
BRN 907218
Kwanciyar hankali: Yana haifar da haushi ga fata, ido da numfashi.
Bayanin Tushen Bayanan CAS 535-80-8 (Tushen Bayanan CAS)
NIST Chemistry Reference Benzoic acid, 3-chloro-(535-80-8)
Tsarin Rijistar Magungunan EPA m-Chlorobenzoic acid (535-80-8)
Bayanin hulda
Kamfanin Masana'antu na MIT-IVY, LTD
Wurin shakatawa na masana'antar sinadarai, Titin Guozhuang 69, gundumar Yunlong, birnin Xuzhou, lardin Jiangsu, kasar Sin 221100
TEL: 0086- 17363307174 FAX: 0086-0516-83666375
WHATSAPP:0086- 17363307174 EMAIL: Kevin@MIT-IVY.COM
Lokacin Saƙo: Oktoba-08-2024






